Structure and function of heparin and heparan sulfate; Heparinoid library and modification of FGF-activities

被引:66
作者
Ishihara, M
Ono, K
机构
[1] Natl Def Med Coll, Inst Res, Div Biomol Engn, Tokorozawa, Saitama 359, Japan
[2] Natl Def Med Coll, Dept Surg 2, Tokorozawa, Saitama 359, Japan
关键词
fibroblast growth factor; heparan sulfate; heparin; heparinoid library; proteoglycan;
D O I
10.4052/tigg.10.223
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The various activities of heparin and heparan sulfate depend mainly on interactions of the polysaccharides with various functional proteins, mediated by specific domains with distinct saccharide sequences. For example, interaction of members of the FGF family with heparin and heparan sulfate requires different combinations of sulfate groups, hence different saccharide sequences. The sulfate groups mentioned above can be modified or substituted to introduce structural changes to the polysaccharides. Several such changes have been already performed on heparin in order to modulate the biological activities of FGF.
引用
收藏
页码:223 / 233
页数:11
相关论文
共 36 条
[1]
CHARACTERIZATION OF HEPARAN-SULFATE OLIGOSACCHARIDES THAT BIND TO HEPATOCYTE GROWTH-FACTOR [J].
ASHIKARI, S ;
HABUCHI, H ;
KIMATA, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (49) :29586-29593
[2]
GROWTH-INHIBITION IN-VITRO OF MURINE MAMMARY ADENOCARCINOMA CELLS BY HEPARIN AND CHEMICALLY-MODIFIED HEPARINS [J].
BERTOLESI, GE ;
DECIDRE, LL ;
EIJAN, AM .
TUMOR BIOLOGY, 1994, 15 (05) :275-283
[3]
GLYCOSAMINOGLYCANS AND THE REGULATION OF BLOOD-COAGULATION [J].
BOURIN, MC ;
LINDAHL, U .
BIOCHEMICAL JOURNAL, 1993, 289 :313-330
[4]
STRUCTURAL DETERMINANTS OF THE CAPACITY OF HEPARIN TO INHIBIT THE PROLIFERATION OF VASCULAR SMOOTH-MUSCLE CELLS [J].
CASTELLOT, JJ ;
BEELER, DL ;
ROSENBERG, RD ;
KARNOVSKY, MJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 1984, 120 (03) :315-320
[5]
MODIFICATIONS OF LOW-DENSITY-LIPOPROTEIN INDUCED BY THE INTERACTION WITH HUMAN PLASMA GLYCOSAMINOGLYCAN PROTEIN COMPLEXES [J].
CHERCHI, GM ;
FORMATO, M ;
DEMURO, P ;
MASSERINI, M ;
VARANI, I ;
DELUCA, G .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1994, 1212 (03) :345-352
[6]
NEW ACQUISITIONS IN THE DEVELOPMENT OF ANTI-HIV AGENTS [J].
DECLERCQ, E .
ANTIVIRAL RESEARCH, 1989, 12 (01) :1-19
[7]
Edward Conrad H, 1998, HEPARIN BINDING PROT, P7, DOI [DOI 10.1016/B978-012186060-8/50003-6, 10.1016/B978-012186060-8/50003-6]
[8]
EKRE Y, 1992, ADV EXPT MED BIOL, P329
[9]
ENGELBERG H, 1984, PHARMACOL REV, V36, P91
[10]
ANGIOGENIC FACTORS [J].
FOLKMAN, J ;
KLAGSBRUN, M .
SCIENCE, 1987, 235 (4787) :442-447